TDS PDF

↑
St CLSI MR14-2022

Piperacillin-Tazobactam Breakpoints for Enterobacterales. Original document CLSI MR14-2022 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR15-2024

Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa. Original document CLSI MR15-2024 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR01-2020

Polymyxin Breakpoints for Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. Original document CLSI MR01-2020 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR03-2019

Meropenem Breakpoints for Acinetobacter spp. Original document CLSI MR03-2019 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR04-2019

Azithromycin Breakpoint for Neisseria gonorrhoeae. Original document CLSI MR04-2019 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR05-2019

Ceftaroline Breakpoints for Staphylococcus aureus. Original document CLSI MR05-2019 in PDF full version. Additional info + preview on request

Document status: Active

€35
↑